Chanelle founder invests €100k in Redesdale Group

Michael Burke has taken a stake in a firm that will seek to acquire or invest in early stage food and wellness businesses

21st February, 2021
Chanelle founder invests €100k in Redesdale Group
Michael Burke: managing director of Chanelle Pharmaceuticals. Picture: Michael Dillon

Michael Burke, the founder of Chanelle Pharmaceuticals, has joined veteran financier John Conroy’s Redesdale Group as a shareholder.

Set up by Conroy, the Merrion Capital founder, and formerly called Acton Health & Wellness Fund, Redesdale Group is expected to close an initial funding round in the region of €25 million later this quarter, sources familiar with the venture said.

Burke has invested in the region of €100,000 as part of his involvement in...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Malin shareholders in line for windfall after €119 million cash boost

Amryt seeks to have rare condition drug approved for payment

Icon to restore staff pay as business recovers from virus

Comment: Cutting-edge pharma research can bring investment to Ireland